By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NovoCure Ltd. 



Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Medical Device






Company News
Long-Term Analysis Of All 695 Patients Enrolled In NovoCure’s Phase 3 Pivotal Trial In Newly Diagnosed Glioblastoma Confirms Successful Interim Analysis Results And Demonstrates Superior Two- And Four-Year Survival Rates 11/18/2016 11:42:05 AM
NovoCure Presents Interim STELLAR Results At IASLC Suggesting Treatment With Tumor Treating Fields Plus Chemotherapy May Extend Survival Of Patients With Mesothelioma 11/17/2016 11:26:37 AM
NovoCure Announces 38 Presentations On Tumor Treating Fields At 21st Annual Scientific Meeting Of The Society Of Neuro-Oncology 11/7/2016 11:17:43 AM
NovoCure Reports Third Quarter 2016 Financial Results And Provides Company Update 11/2/2016 10:02:19 AM
NovoCure Release: CNS Oncology Publishes Tumor Treating Fields Treatment Planning And Patient Follow-up Guidelines In Glioblastoma 9/19/2016 10:03:13 AM
NovoCure’s Executive Chairman William Doyle To Present On Tumor Treating Fields At New York Academy Of Sciences’ Symposium On Bioelectronic Medicine 9/15/2016 11:20:13 AM
Two Institutions Publish Independent Data On NovoCure’s Tumor Treating Fields 9/14/2016 11:31:02 AM
Long-term Analysis Of All 695 Patients Enrolled In NovoCure’s Phase 3 Pivotal Trial In Newly Diagnosed Glioblastoma Confirms Superior Progression Free And Overall Survival Seen In The Trial’s Interim Analysis 9/12/2016 12:05:39 PM
NovoCure Release: International Journal Of Cancer Publishes Data Showing Tumor Treating Fields In Combination With Paclitaxel Is Therapeutically Effective Against Ovarian Cancer Cells In Vitro And In Vivo 9/1/2016 10:56:28 AM
NovoCure Converts More Than 500 U.S. Patients To Second Generation Optune Within Four Weeks Of FDA Approval On July 13 8/16/2016 10:08:49 AM
12345678910...
//-->